CymaBay Therapeutics Inc. (CBAY) Dropped -6.28% or -0.83 To Price $12.39 On Friday


CymaBay Therapeutics Inc. (CBAY) dropped -6.28% or -0.83 to $12.39. It is close to 328393 shares traded, which is 36.7% compare to the average total volume 894871. The market cap of CBAY is $736.45 million. The year to date change is 53.77%. The 52 week price range is from $6.31 to $15.21. Price of CBAY have changed 4.18% during last week. It have changed 45.92% over last month, 53.72% over last 3 months, 3.28% over last 6 months and -9.58% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBAY is 9.60. It is -22.52% below current price. The 200-day Moving Averages for CBAY is 11.04. It is -10.90% below current price. The 52-week High is 15.21. It is 22.76% from the current price. The 52-week Low is 6.31. It is -49.07% from current price.

There are some statistics of CBAY. It is has market cap $736.45 million. The share outstanding is 59.44 million. The average volume is 894871. The percent of top 15 Institution holding is 121.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBAY is -42.34%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBAY is -37.75%.


Tags:

Share this post